First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Ben Sessa; Chloe Sakal; Steve O’Brien; David Nutt

doi:10.1136/bcr-2019-230109

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Novel treatment (new drug/intervention; established drug/procedure in new situation)

CASE REPORT

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Online download statistics by month:

Online download statistics by month: July 2019 to February 2020

	Abstract	Full	Pdf
Jul 2019	7408	190	20
Aug 2019	5291	43	33
Sep 2019	3816	23	14
Oct 2019	1012	18	22
Nov 2019	1233	20	15
Dec 2019	805	2	2
Jan 2020	538	8	10
Feb 2020	291	5	2
Total	20394	309	118

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: July 2019 to February 2020

Read the full text or download the PDF:

Log in using your username and password